CKD in India 2026 | Chronic Kidney Disease Statistics | Year-by-Year Data | AaharIQ

Schema Type: MedicalWebPage + Dataset

Chronic Kidney Disease has become one of India's most rapidly escalating non-communicable disease crises, yet it remains drastically underfunded and underrecognised relative to its scale. India accounts for approximately 12–17% of the global CKD burden despite representing only 18% of the world population — a disproportionate share driven by the co-epidemic of uncontrolled diabetes and hypertension that affects India more severely than most nations.

The burden of CKD is not just medical — it is economic. Renal replacement therapy (dialysis or transplant) costs ₹3–6 lakh annually per patient, and the vast majority of India's estimated 10–15 million patients requiring dialysis cannot access or afford it. Prevention and early dietary management are therefore not merely clinical priorities — they are economic and public health imperatives.

Approximately 220,000 new patients require dialysis annually in India, but only 75,000–90,000 receive it — meaning more than 60% of Indians who need renal replacement therapy cannot access it. Government schemes like Pradhan Mantri National Dialysis Programme (PMNDP) have expanded capacity, but shortfalls remain severe, particularly in Tier-3 cities and rural areas.

The cost of haemodialysis ranges from ₹300–1,200 per session, with patients typically requiring 3 sessions per week (144+ sessions per year). Even at subsidised rates, this represents ₹40,000–80,000 annually — unaffordable for the majority of CKD patients who come from lower-income groups. Every month of delayed kidney failure through dietary management directly translates to financial survival for these patients.

A 2021 systematic review in the Clinical Journal of the American Society of Nephrology documented that inorganic phosphate additives in processed food are 90–100% bioavailable compared to 40–60% for natural food phosphorus. This means processed food phosphorus is nearly twice as dangerous per milligram for CKD patients as the same amount of phosphorus in whole foods.

CKD patients who regularly consume processed food with inorganic phosphate additives may be getting 2× the effective phosphorus load compared to what any nutrition label shows, because labels list total phosphorus — not bioavailability. AaharIQ flags every inorganic phosphate additive in the ingredient list.

AaharIQ currently offers a dedicated kidney health filter that identifies: all sodium sources per serving, all phosphate additives in the ingredient list (with a flag when inorganic phosphate additives are detected), potassium content where declared on the label, and protein content per 100g and per serving.

Planned kidney health features include: a potassium calculator that estimates total daily potassium from all scanned products, a phosphate additive database mapped to Indian packaged food brands, integration with eGFR-based stage recommendations (so a Stage 3 patient gets different alerts than a Stage 1 patient), and an alert when a product is marketed as "healthy" but contains multiple kidney-stressing ingredients.

Q: Which state in India has the highest CKD burden?

Punjab (18.3%) and Andhra Pradesh (17.8%) show the highest documented CKD prevalence. Punjab's burden is driven by a combination of agricultural chemical exposure (organophosphate pesticides) and high diabetes prevalence. Andhra Pradesh faces both the highest diabetes burden in India and documented environmental nephrotoxins including fluoride-contaminated water in certain districts.

Q: How many Indians are on dialysis?

Approximately 75,000–90,000 Indians receive regular dialysis, out of an estimated 220,000 new patients who need it annually. The rest — over 130,000 new patients each year — cannot access renal replacement therapy due to cost, distance, or availability constraints. Peritoneal dialysis is available to approximately 5,000–8,000 patients.

Q: What is the main cause of kidney failure in India?

Diabetes mellitus (40–42%) and hypertension (25–30%) together account for 65–72% of all CKD cases in India — reflecting the country's twin epidemics of both conditions. Glomerulonephritis (immune-mediated) accounts for another 10–15%. Agricultural nephropathy (from pesticide and heavy metal exposure) is a significant but underquantified cause in farming communities.